Seth Klarman · Q2 2016
Baupost Group
Portfolio at the end of Q2 2016, from the 13F filed August 12, 2016. See the filing on EDGAR ↗
| Company | Weight | Held since | Change |
|---|---|---|---|
| EMC EMC · history | 21.0% | Q4 2015 | Add 10% |
| Cheniere Energy LNG · history | 15.2% | Q1 2014 | No change |
| Viasat VSAT · history | 11.2% | Q2 2013 or earlier | No change |
| Allergan AGN · history | 6.3% | Q1 2016 | Add 16% |
| Antero Resources AR · history | 5.1% | Q3 2014 | Reduce 33% |
| Olin OLN · history | 3.6% | Q3 2015 | No change |
| PBF Energy PBF · history | 3.4% | Q3 2013 | No change |
| Citigroup C · history | 3.0% | Q2 2016 | Buy |
| Twenty-First Century Fox FOXA · history | 2.8% | Q3 2015 | No change |
| PayPal PYPL · history | 2.8% | Q3 2015 | Reduce 20% |
| Twenty-First Century Fox FOX · history | 2.7% | Q3 2015 | No change |
| Innoviva INVA · history | 2.5% | Q2 2013 or earlier | Reduce 11% |
| Keryx Biopharmaceuticals KERX · history | 2.3% | Q1 2014 | No change |
| Theravance Biopharma TBPH · history | 2.3% | Q2 2014 | Add 13% |
| VMware VMW · history | 1.7% | Q1 2016 | No change |
| Atara Biotherapeutics ATRA · history | 1.6% | Q4 2014 | No change |
| Veritiv VRTV · history | 1.6% | Q3 2014 | No change |
| Forward Pharma FWP · history | 1.3% | Q4 2014 | No change |
| Qurate Retail QVCA · history | 1.2% | Q2 2016 | Buy |
| ChipMOS IMOS · history | 0.9% | Q2 2013 or earlier | No change |
| KLX KLXI · history | 0.8% | Q1 2015 | No change |
| Novagold Resources NG · history | 0.8% | Q2 2013 or earlier | Reduce 37% |
| Avis Budget Group CAR · history | 0.8% | Q2 2016 | Buy |
| SunEdison Semiconductor SEMI · history | 0.7% | Q2 2014 | No change |
| American International Group AIG.WS · warrants · history | 0.6% | Q2 2013 or earlier | Add 20% |
| Atlanta Braves Holdings BATRK · history | 0.6% | Q2 2016 | Buy |
| Innoviva INVA.CV · convertible notes · history | 0.5% | Q3 2014 | No change |
| Silver Run Acquisition SRAQ · history | 0.5% | Q2 2016 | Buy |
| Paratek Pharmaceuticals PRTK · history | 0.4% | Q4 2014 | Add 32% |
| Cascadian Therapeutics CASC · history | 0.3% | Q2 2016 | Buy |
| Credit Acceptance CACC · history | 0.3% | Q2 2016 | Buy |
| Sunrun RUN · history | 0.2% | Q3 2015 | No change |
| Sculptor Capital OZM · history | 0.2% | Q2 2016 | Buy |
| Atlanta Braves Holdings BATRA · history | 0.2% | Q2 2016 | Buy |
| Kindred Biosciences KIN · history | 0.1% | Q4 2013 | No change |
| Orexigen Therapeutics OREX · history | 0.1% | Q3 2015 | No change |
| Citigroup C.WS · warrants · history | 0.1% | Q2 2013 or earlier | No change |
| Trilogy Metals TMQ · history | 0.1% | Q2 2013 or earlier | No change |
| Silver Run Acquisition SRAQ.WS · warrants · history | 0.0% | Q2 2016 | Buy |
| 39 positions | 100.0% |
Weight is the position's share of the total value in this 13F, not of the whole fund. Price is the value divided by the number of shares, so it's the price at the end of the quarter, as the firm reported it. Change compares share counts with Q1 2016, adjusted for stock splits.
Sector weighting
| Technology | 24.4% | |
|---|---|---|
| Energy | 23.8% | |
| Health care | 17.8% | |
| Media & telecom | 17.5% | |
| Financials & real estate | 7.5% | |
| Materials | 4.5% | |
| Industrials | 2.6% | |
| Consumer discretionary | 1.2% | |
| Other | 0.8% |
What changed from Q1 2016
- Buy Citigroup C 3.0% of the 13F
- Buy Qurate Retail QVCA 1.2% of the 13F
- Buy Avis Budget Group CAR 0.8% of the 13F
- Buy Atlanta Braves Holdings BATRK 0.6% of the 13F
- Buy Silver Run Acquisition SRAQ 0.5% of the 13F
- Buy Cascadian Therapeutics CASC 0.3% of the 13F
- Buy Credit Acceptance CACC 0.3% of the 13F
- Buy Sculptor Capital OZM 0.2% of the 13F
- Buy Atlanta Braves Holdings BATRA 0.2% of the 13F
- Buy Silver Run Acquisition SRAQ.WS 0.0% of the 13F
- Add 10% EMC EMC 20.0% → 21.0%
- Add 16% Allergan AGN 6.7% → 6.3%
- Add 13% Theravance Biopharma TBPH 1.8% → 2.3%
- Add 20% American International Group AIG.WS 0.6% → 0.6%
- Add 32% Paratek Pharmaceuticals PRTK 0.3% → 0.4%
- Reduce 33% Antero Resources AR 7.7% → 5.1%
- Reduce 20% PayPal PYPL 3.9% → 2.8%
- Reduce 11% Innoviva INVA 3.6% → 2.5%
- Reduce 37% Novagold Resources NG 1.1% → 0.8%
- Sell Silver Run Acquisition SRAQ.U was 0.6%
- Sell Biotie Therapies BITI was 0.5%
- Sell Chesapeake Energy CHK.CV was 0.3%
- Sell La Quinta LQ was 0.2%
- Sell Bellatrix Exploration BXE was 0.1%
- Sell Genworth Financial GNW was 0.1%